FDA Approved: BRUKINSA — Original Application (BeOne Medicines USA, Inc.)

View source ↗

Summary

The FDA approved the original application for Brukinsa (zanubrutinib) from BeOne Medicines USA, Inc., marking the U.S. approval of this BTK inhibitor for multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)

Snippet

ORIG AP for BRUKINSA (ZANUBRUTINIB)